MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
156 hedge funds and large institutions have $1.02B invested in Momenta Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 66 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less capital invested
Capital invested by funds: $1.4B → $1.02B (-$384M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
156
Holding in Top 10
–
Calls
$5.78M
Puts
$3.37M
Top Buyers
| 1 | +$20.6M | |
| 2 | +$12.7M | |
| 3 | +$10M | |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
+$8.23M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.08M |
Top Sellers
| 1 | -$43.6M | |
| 2 | -$9.81M | |
| 3 | -$4.69M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.34M |
| 5 |
CCMU
Cheyne Capital Management (UK)
London,
United Kingdom
|
-$4.27M |